Medical Devices · Published Aug 2026
Endotracheal Tube Market
The global Endotracheal Tube market was valued at USD 2228.1 Billion in 2025 and is projected to reach USD 4027.99 Billion by 2035, expanding at a CAGR of 6.1% over the forecast period.
Market size
Growth trajectory through 2035
Endotracheal Tube Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025
- 2025: Medtronic launched its new Endotracheal Tube product, which features advanced materials and improved patient safety.
-
2026
- 2026: Abbott announced the acquisition of Boston Scientific's Endotracheal Tube business, expanding its presence in the market.
Emerging opportunities added
- Development of Advanced Materials The development of advanced materials for endotracheal tubes offers opportunities for improved patient safety and comfort.
- Increased Adoption of Single-Use Endotracheal Tubes The increasing adoption of single-use endotracheal tubes can reduce the risk of complications and improve patient outcomes.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $2.23 Bn
- CAGR
- 6.10%
- Expansion
- 1.8×
Market shape
top segment · 59.5% share
- Leading region
- North America
- Top end-user
- Hospitals
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Cost of Endotracheal Tubes
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
2025: Medtronic launched its new Endotracheal Tube product, which features advanced materials and improved patient safety
+1 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 105-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Endotracheal Tube Market today ($2.23 Bn base), and how fast will it grow at 6.1% CAGR through 2035?
- Which of Cuffed Endotracheal Tubes, Uncuffed Endotracheal Tubes, Reinforced Endotracheal Tubes and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Anesthesia, Intensive Care Units, Emergency Procedures applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Philips Healthcare, Medtronic plc, Abbott Laboratories and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Rising Incidence of Respiratory Disorders) and top restraints (led by High Cost of Endotracheal Tubes), with quantified CAGR impact?
- What regulatory shifts and 2 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Rising Incidence of Respiratory Disorders The increasing prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is a primary driver for the Endotracheal Tube Market.
- Technological Innovations in Medical Devices Technological advancements in medical devices are significantly influencing the Endotracheal Tube Market, with innovations such as video laryngoscopes and advanced tube designs enhancing the ease of intubation and improving patient safety.
- Improved Access to Healthcare Services Improved access to healthcare services and the establishment of advanced medical centers contribute to the increased utilization of endotracheal tubes for airway management.
Restraints
Holding it back
- High Cost of Endotracheal Tubes The high cost of endotracheal tubes is a significant restraint for the market, as it limits the adoption of these devices in developing countries.
- Stringent Regulatory Requirements Stringent regulatory requirements and the need for frequent product recalls can hinder the growth of the market.
- Intolerance to Materials Intolerance to materials used in endotracheal tubes can lead to complications and limit the adoption of these devices.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Incidence of Respiratory Disorders | +2.7% | Global | 2025–2035 |
| Technological Innovations in Medical Devices | +1.7% | Global | 2025–2035 |
| Improved Access to Healthcare Services | +1.3% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Cost of Endotracheal Tubes | −1.1% | Global | 2025–2029 |
| Stringent Regulatory Requirements | −0.7% | Global | 2025–2029 |
| Intolerance to Materials | −0.5% | Global | 2025–2029 |
5 Cuffed Endotra 4 Uncuffed Endot 3 Reinforced End 2 Preformed Endo 1 Double Lumen The Endotracheal Tube market is segmented by product type and application.
Revenue share by type · 2025 base year
% OF $2.23 BN ENDOTRACHEAL TUBE MARKET · 2 TYPES COVERED
Each slice = that type's share of the total $2.23 Bn Endotracheal Tube Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Cuffed Endotracheal Tubes
-
Uncuffed Endotracheal Tubes
-
Reinforced Endotracheal Tubes
-
Preformed Endotracheal Tubes
-
Double Lumen
By application
-
Anesthesia
-
Intensive Care Units
-
Emergency Procedures
By end-user industry
-
Hospitals
-
Ambulatory Surgical Centers
-
Emergency Medical Services
-
Home Care Settings
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $2.23 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~40.9% in 2025. The North American market is expected to witness significant growth, driven by the increasing adoption of advanced medical devices and the presence of major players in the region
Per-region detail
-
North America
The North American market is expected to witness significant growth, driven by the increasing adoption of advanced medical devices and the presence of major players in the region
-
Europe
The European market is expected to grow at a moderate pace, driven by the increasing awareness of infection control and the adoption of single-use endotracheal tubes
-
Asia-Pacific
The Asia-Pacific market is expected to witness significant growth, driven by the increasing adoption of advanced medical devices and the growing middle class in the region
-
Latin America
The Latin American market is expected to grow at a moderate pace, driven by the increasing adoption of single-use endotracheal tubes and the growing healthcare infrastructure in the region
-
Middle East & Africa
The Middle East and African market is expected to witness significant growth, driven by the increasing adoption of advanced medical devices and the growing healthcare infrastructure in the region
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The Endotracheal Tube market is highly competitive, with major players such as Medtronic, Abbott, Boston Scientific, Stryker, Baxter, Becton Dickinson, BD, Zimmer Biomet, Smith+Nephew, and Edwards Lifesciences.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Philips Healthcare
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Medtronic plc
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Abbott Laboratories
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Johnson & Johnson MedTech
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Stryker Corporation
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Becton, Dickinson and Company
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Boston Scientific Corporation
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Siemens Healthineers
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA classifies devices by risk (Class I/II/III). 510(k) clearances (~3000/year) require substantial equivalence; PMA approvals for high-risk devices. Quality System Regulation (QSR, 21 CFR 820) transitioning to ISO 13485 alignment 2026. UDI unique device identification mandatory. FDA cybersecurity guidance for connected devices.
-
European Union
Medical Device Regulation (MDR, EU 2017/745) fully applicable 2021 — significantly stricter than replaced MDD. IVDR (in vitro diagnostics) applicable 2022. Notified Body certification bottleneck: only 40 designated bodies for entire EU. Unique Device Identification (UDI) mandatory. EUDAMED database launching in phases.
-
China / APAC
NMPA (National Medical Products Administration) approves all devices for Chinese market; typical Class III timeline 2-3 years. Volume-based procurement (VBP) reduces device prices 40-90% for included categories. Japan's PMDA aligned with FDA on many pathways. India's CDSCO expanded device oversight since 2017.
-
Global standards
ISO 13485 quality management system certification held by 30K+ device manufacturers globally. ISO 14971 risk management mandatory in most jurisdictions. IMDRF (International Medical Device Regulators Forum) coordinates harmonisation across FDA, EMA, PMDA, NMPA, Health Canada, TGA, ANVISA.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,350
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,950
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$6,950
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Endotracheal Tube Market in 2025?
The Endotracheal Tube Market is estimated at approximately $2.23 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 6.10% CAGR from 2025 to 2035, reaching $4.03 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 40.9% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Cuffed Tubes leads the type segmentation with an estimated 59.5% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Philips Healthcare, Medtronic plc, Abbott Laboratories, Johnson & Johnson MedTech, Stryker Corporation, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Rising Incidence of Respiratory Disorders. The increasing prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is a primary driver for the Endotracheal Tube Market.
-
What are the main restraints?
The primary restraint is High Cost of Endotracheal Tubes. The high cost of endotracheal tubes is a significant restraint for the market, as it limits the adoption of these devices in developing countries.
-
What are the most recent developments?
Recent notable events include: 2025: 2025: Medtronic launched its new Endotracheal Tube product, which features advanced materials and improved patient safety; 2026: 2026: Abbott announced the acquisition of Boston Scientific's Endotracheal Tube business, expanding its presence in the market. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Endotracheal Tube Market is projected to reach $4.03 Bn by 2035, up from $2.23 Bn in 2025 — a 6.10% CAGR equating to roughly 1.8× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.